Clinical Trial Update: Targeting Inflammation Using Salsalate in CardioVascular Disease [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating salsalate to target inflammation in cardiovascular disease; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Overweight

Drugs mentioned

• Salsalate (Salsalate)

Snippet

Sponsor: Joslin Diabetes Center | Conditions: Coronary Artery Disease, Overweight | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-12-12